Medical Pharmaceuticals The most-up-to-date pharmaceutical news stories, including medical, cosmetic, and supplemental treatments. This section contains releases covering all aspects of the pharmaceutical sector, from research, development, and testing, through to product launches and marketing. Topics include clinical trials and studies, as well as updates on the FDA approval process for new treatment options. Learn about upcoming events, conferences, and educational initiatives. Also included is financial and corporate information from the sector, such as board decisions, appointments and changes, industry awards, and quarterly reports.

Latest

28 Apr, 2017, 12:00 ET Insufflator Market 2022 Global Analysis and Forecasts Research Report Now Available ReportsnReports.com

Insufflator industry 2017 research report is an in-depth study and analysis of the market by our industry experts with unparalleled domain...


28 Apr, 2017, 11:43 ET Novartis receives FDA approval for Rydapt® in newly diagnosed FLT3-mutated acute myeloid leukemia (AML) and three types of systemic mastocytosis (SM)

Novartis announced today the US Food and Drug Administration (FDA) has approved Rydapt® (midostaurin, formerly PKC412) for two indications. The...


28 Apr, 2017, 11:29 ET Astellas Announces Key Leadership Promotions in Development Organization

Astellas today announced three recent senior-level promotions within its Development organization. Joseph Fleishaker, Ph.D., FAAPS, FCP, was...


28 Apr, 2017, 10:30 ET Deep Learning Luminary Yoshua Bengio Joins Recursion Pharmaceuticals as Key Advisor

Recursion Pharmaceuticals, an emerging biotechnology company that combines innovative biological science with machine learning techniques to...


28 Apr, 2017, 10:07 ET FDA approves new combination treatment for acute myeloid leukemia

The U.S. Food and Drug Administration today approved Rydapt (midostaurin) for the treatment of adult patients with newly diagnosed acute myeloid...


28 Apr, 2017, 09:30 ET Easy Technological Accessibility Driving the Demand for Teleradiology Across the Globe

According to National Institute of Cancer, 448.7 new cancer cases per 100,000 men and women are diagnosed each year in the US. Taking into...


28 Apr, 2017, 09:30 ET Blood Group Typing Market Worth 3.12 Billion USD by 2021

According to a new market research report "Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO,...


28 Apr, 2017, 09:12 ET Hybrid Healthcare Pioneer Appoints Top Texas Hospital Executive to Its Board

Legacy ER & Urgent Care, a Plano, Texas-based operator and pioneer of Hybrid community-based healthcare facilities has appointed Dan Wolterman...


28 Apr, 2017, 09:00 ET Sorrento Therapeutics Announces Closing of its Acquisition of Virttu Biologics

Sorrento Therapeutics, Inc. (NASDAQ: SRNE, "Sorrento") announced today the closing of a transaction whereby its cellular therapy focused...


28 Apr, 2017, 09:00 ET Rodo Medical and Straumann Group enter into Distribution Agreement Outside North America; Straumann Increases Its Investment in Rodo Medical

Rodo Medical and Straumann announced that Straumann has increased its stake in Rodo Medical Inc. from 12% (obtained in 2014) to 30%, for an...


28 Apr, 2017, 09:00 ET Memorial Hermann Katy Hospital Earns Statewide Recognition for Quality and High Performance

The Quality Texas Foundation has awarded Memorial Hermann Katy Hospital the Texas Award for Performance Excellence (TAPE). The prestigious award...


28 Apr, 2017, 09:00 ET Investigational Cladribine Tablets Data Show Greater Treatment Effect in Relapsing MS Patients at a Higher Risk of Disease Progression

EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced the presentation of new analyses of...


28 Apr, 2017, 08:45 ET Europe Biosimilars Market 2017-2025: 30 Companies are Actively Developing Biosimilar Medicines With 8 Major Biologic Medicines Expected to Lose Exclusivity by 2020 - Research and Markets

Research and Markets has announced the addition of the "Europe: Biosimilars Market - Forecast to 2025" report to their offering. The study...


28 Apr, 2017, 08:30 ET Allergan Successfully Completes ZELTIQ® Aesthetics Acquisition

Allergan plc (NYSE: AGN), a leading global biopharmaceutical company, today announced it has successfully completed the acquisition of ZELTIQ®...


28 Apr, 2017, 08:30 ET Juniper Pharmaceuticals to Report First Quarter 2017 Results on May 4, 2017

Juniper Pharmaceuticals (Nasdaq: JNP) ("Juniper" or the "Company"), will hold a conference call on May 4, 2017, to discuss the financial results...


28 Apr, 2017, 08:25 ET Mallinckrodt Data from New Company-Sponsored Studies Presented at American Academy of Neurology 69th Annual Meeting

Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical company, announced new results from two company-sponsored studies: one...


28 Apr, 2017, 08:00 ET Olympus объявляет о своём намерении приобрести Image Stream Medical, Inc. с целью расширения ассортимента медицинских решений для сферы здравоохранения

Приобретаемая компания войдёт в состав передового предприятия-поставщика минимально инвазивных диагностических и терапевтических решений и пионера...


28 Apr, 2017, 08:00 ET Centene To Present At Deutsche Bank Annual Health Care Conference

Centene Corporation (NYSE: CNC) announced today it will present at the Deutsche Bank 42nd Annual Health Care Conference to be held May 3-4, 2017,...


28 Apr, 2017, 08:00 ET BiondVax Announces Fourth Quarter and Full Year 2016 Financial Results and Update

BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV; TASE: BVXV), a clinical stage biopharmaceutical company focused on developing and commercializing...


28 Apr, 2017, 08:00 ET Olympus kündigt beabsichtigte Übernahme von Image Stream Medical, Inc. für verbessertes Angebot medizinischer Lösungen für Gesundheitseinrichtungen an

Übernahme vereint führenden Anbieter von minimal-invasiver Diagnostik und therapeutischen Lösungen mit Pionier für Systemintegration Am 28....


28 Apr, 2017, 07:51 ET CytRx Corporation Announces Pricing of $15 Million Public Offering of Common Stock

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it has priced...


28 Apr, 2017, 07:30 ET Neurotrope Bioscience to Release Results From Phase 2 Clinical Trial in Moderate to Severe Alzheimer's Disease on May 1, 2017

Neurotrope, Inc. (Nasdaq: NTRP), a clinical-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases, including...


28 Apr, 2017, 07:30 ET Sanofi Delivers Robust Q1 2017 Financial Results

Sanofi (NYSE: SNY; EURONEXT: SAN) Q1 2017 Change Change at CER Change...


28 Apr, 2017, 07:30 ET New research suggests current genetic testing guidelines may miss breast cancer patients who could benefit from testing

New research suggests that current clinical guidelines on the use of genetic testing in breast cancer patients are too narrow and allow patients...


28 Apr, 2017, 07:00 ET Research Reports Initiation on Medical Stocks -- Microbot Medical, Cooper Cos., Dextera Surgical, and ConforMIS

On Thursday, April 27, 2017, US markets saw broad based gains with six out of nine sectors finishing the trading sessions in green. Major US...